バソプレッサーの世界市場レポート 2025年

バソプレッサー市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.9％で、49億2,000万米ドルに成長します。予測期間中の成長は、高血圧の罹患率の上昇、高度敗血症管理ガイドラインの採用拡大、クリティカルケア技術への投資の増加、敗血症性ショックの有病率の上昇、個別化クリティカルケアに対する需要の高まりなど、いくつかの要因に起因しています。この期間の主な動向には、薬剤製剤の進歩、テーラーメイド療法の開発、スマート輸液ポンプの技術革新、遠隔医療とバソプレッサー療法の統合、生分解性バソプレッサーインプラントの技術革新などがあります。

心臓疾患の有病率の増加は、今後数年間のバソプレッサー市場の拡大に拍車をかけると予想されています。心臓病には、冠動脈疾患、不整脈、心不全、先天性心疾患など、心臓の構造や機能に影響を及ぼすさまざまな疾患が含まれます。座りがちなライフスタイルの増加に伴い、肥満や心血管系の健康状態の悪化が一般的になりつつあり、心臓に関連する疾患のリスクが大幅に高まっています。血管収縮薬は、血管を収縮させることで血圧を上昇させ、重要な臓器への血流を促進し、重要な状態における心血管系の機能をサポートすることで、心臓病の治療を助けます。例えば、2023年12月、オーストラリアの政府機関であるオーストラリア保健福祉研究所は、冠動脈性心疾患（CHD）による医師認定の死亡者数が2021年の1万4,100人から2022年には1万4,900人に増加したと報告しました。その結果、心臓病の増加率がバソプレッサー市場の成長に寄与しています。

バソプレッサー市場の新興国企業は、血圧をより適切に調整し、患者の予後を改善するために、静脈内（IV）血管圧迫薬などの高度なソリューションの開発に注力しています。静脈内バソプレッサーは、重度の低血圧やショック状態にある患者の血管を収縮させ、血圧を上昇させることにより、重要な臓器への十分な血流を確保するために使用されます。例えば、ドイツに本社を置く製薬会社フレゼニウス・カビAGは、2023年6月、バソストリクトのジェネリック医薬品であるバソプレッシン注射液USPを米国市場に導入し、クリティカルケア製品のラインアップを拡充しました。本剤は、輸液やカテコールアミンの投与後も低血圧が持続する血管拡張性ショックの成人に特に適応があります。本剤は、1mLあたり20単位を含む1回投与用バイアルです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界バソプレッサーPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のバソプレッサー市場：成長率分析
• 世界のバソプレッサー市場の実績：規模と成長, 2019-2024
• 世界のバソプレッサー市場の予測：規模と成長, 2024-2029, 2034F
• 世界バソプレッサー総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のバソプレッサー市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カテコールアミン
• 非カテコールアミン
• バソプレシン
• 世界のバソプレッサー市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 静脈内（IV）
• 骨内
• 吸入
• 世界のバソプレッサー市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低血圧管理
• 敗血症性ショックの治療
• 心臓性ショックサポート
• 術後管理
• その他の集中治療アプリケーション
• 世界のバソプレッサー市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• 救急医療サービス
• 在宅ケア設定
• 世界のバソプレッサー市場カテコールアミンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ノルエピネフリン
• エピネフリン
• ドーパミン
• イソプロテレノール
• 世界のバソプレッサー市場、非カテコールアミンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェニレフリン
• アンジオテンシンII
• 世界のバソプレッサー市場バソプレシンの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• バソプレシン（デスモプレシン）

第7章 地域別・国別分析

• 世界のバソプレッサー市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のバソプレッサー市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• バソプレッサー市場：競合情勢
• バソプレッサー市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bauch & Lomb Incorporated
• Dr. Reddy's Laboratories Limited
• Hikma Pharmaceuticals PLC
• Endo Inc.
• Amphastar Pharmaceuticals Inc.
• American Regent Incorporated
• Celon Laboratories Ltd.
• Athenex Inc.
• Sagent Pharmaceuticals Inc.
• Civica Rx
• Eton Pharmaceuticals Inc.
• Amomed Pharma GmbH
• Health Biotech Limited
• Samarth Life Sciences Pvt. Ltd
• Pace Biotech Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• バソプレッサー市場2029：新たな機会を提供する国
• バソプレッサー市場2029：新たな機会を提供するセグメント
• バソプレッサー市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A vasopressor is a drug that constricts blood vessels, raising blood pressure by enhancing vascular tone. It is primarily used in critical care to manage severe hypotension and ensure adequate blood flow to vital organs. By stabilizing circulation, vasopressors help prevent life-threatening complications in critically ill patients.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of vasopressors include catecholamines, non-catecholamines, and vasopressin. Catecholamines are hormones such as dopamine, norepinephrine, and epinephrine, produced by the adrenal glands and involved in the body's stress response. These drugs can be administered through various routes, such as intravenous (IV), intraosseous, and inhalational methods, for applications such as managing hypotension, treating septic shock, supporting cardiogenic shock, post-surgical management, and others. They are used in various settings, including hospitals, ambulatory surgical centers, emergency medical services, and home care.

The vasopressor market research report is one of a series of new reports from The Business Research Company that provides vasopressor market statistics, including vasopressor industry global market size, regional shares, competitors with a vasopressor market share, detailed vasopressor market segments, market trends and opportunities, and any further data you may need to thrive in the vasopressor industry. This vasopressor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vasopressor market size has grown strongly in recent years. It will grow from$3.51 billion in 2024 to $3.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to several factors, including the increasing geriatric population, rising healthcare expenditure, expanding government initiatives, a growing number of hospitals, and the increasing prevalence of cardiovascular diseases.

The vasopressor market size is expected to see strong growth in the next few years. It will grow to$4.92 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to several factors, including the rising incidence of hypertension, greater adoption of advanced sepsis management guidelines, increasing investments in critical care technologies, the growing prevalence of septic shock, and a rising demand for personalized critical care. Key trends during this period include advancements in drug formulations, the development of tailored therapies, technological innovations in smart infusion pumps, the integration of telemedicine with vasopressor therapy, and innovations in biodegradable vasopressor implants.

The growing prevalence of heart diseases is anticipated to fuel the expansion of the vasopressor market in the coming years. Heart diseases encompass a range of conditions that affect the heart's structure and functionality, including coronary artery disease, arrhythmias, heart failure, and congenital heart defects. With the rise in sedentary lifestyles, obesity and poor cardiovascular health are becoming more common, substantially elevating the risk of heart-related conditions. Vasopressors aid in the treatment of heart disease by constricting blood vessels, which helps raise blood pressure and enhance blood flow to vital organs, thus supporting cardiovascular function during critical states. For example, in December 2023, the Australian Institute of Health and Welfare, a government agency in Australia, reported that doctor-certified deaths due to coronary heart disease (CHD) rose from 14,100 in 2021 to 14,900 in 2022. Consequently, the increasing rate of heart disease is contributing to the growth of the vasopressor market.

Leading players in the vasopressor market are concentrating on the development of advanced solutions such as intravenous (IV) vasopressors to better regulate blood pressure and improve patient outcomes. IV vasopressors are employed to constrict blood vessels and raise blood pressure in patients suffering from severe hypotension or shock, thereby ensuring sufficient blood flow to essential organs. For instance, in June 2023, Fresenius Kabi AG, a pharmaceutical company based in Germany, introduced Vasopressin Injection, USP, a generic version of Vasostrict, in the U.S. market, broadening its critical care product lineup. This drug is specifically indicated for adults experiencing vasodilatory shock who remain hypotensive after receiving fluids and catecholamines. It comes in a single-dose vial containing 20 units per 1 mL.

In April 2024, Endo Inc., a pharmaceutical company based in the United States, acquired assets from Endo International plc (EIP) for an undisclosed amount. Through this acquisition, Endo Inc. aims to enhance its financial stability, expand its product range, foster innovation, gain operational efficiencies, and strategically position itself for future growth in the pharmaceutical sector. Endo International plc, headquartered in Ireland, is a pharmaceutical firm known for manufacturing and distributing vasopressin.

Major players in the vasopressor market are Pfizer Inc., Merck And Co Inc., Novartis AG, Baxter International Inc., Fresenius Kabi AG, Bauch & Lomb Incorporated, Dr. Reddy's Laboratories Limited, Hikma Pharmaceuticals PLC, Endo Inc., Amphastar Pharmaceuticals Inc., American Regent Incorporated, Celon Laboratories Ltd., Athenex Inc., Sagent Pharmaceuticals Inc., Civica Rx, Eton Pharmaceuticals Inc., Amomed Pharma GmbH, Health Biotech Limited, Samarth Life Sciences Pvt. Ltd, and Pace Biotech Limited.

North America was the largest region in the vasopressor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in vasopressor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vasopressor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vasopressor market consists of sales of norepinephrine, epinephrine, dopamine, and phenylephrine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vasopressor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vasopressor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vasopressor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasopressor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Catecholamines; Non-Catecholamines; Vasopressin
• 2) By Route Of Administration: Intravenous (IV); Intraosseous; Inhalational
• 3) By Applications: Hypotension Management; Septic Shock Treatment; Cardiogenic Shock Support; Post-Surgical Management; Other Critical Care Applications
• 4) By End Users: Hospitals; Ambulatory Surgical Centers; Emergency Medical Services; Home Care Settings
• Subsegments:-
• 1) By Catecholamines: Norepinephrine; Epinephrine; Dopamine; Isoproterenol
• 2) By Non-Catecholamines: Phenylephrine; Angiotensin II
• 3) By Vasopressin: Vasopressin
• Companies Mentioned: Pfizer Inc.; Merck And Co Inc.; Novartis AG; Baxter International Inc.; Fresenius Kabi AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vasopressor Market Characteristics

3. Vasopressor Market Trends And Strategies

4. Vasopressor Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Vasopressor Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vasopressor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vasopressor Market Growth Rate Analysis
• 5.4. Global Vasopressor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vasopressor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vasopressor Total Addressable Market (TAM)

6. Vasopressor Market Segmentation

• 6.1. Global Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Catecholamines
• Non-Catecholamines
• Vasopressin
• 6.2. Global Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous (IV)
• Intraosseous
• Inhalational
• 6.3. Global Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypotension Management
• Septic Shock Treatment
• Cardiogenic Shock Support
• Post-Surgical Management
• Other Critical Care Applications
• 6.4. Global Vasopressor Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Emergency Medical Services
• Home Care Settings
• 6.5. Global Vasopressor Market, Sub-Segmentation Of Catecholamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Norepinephrine
• Epinephrine
• Dopamine
• Isoproterenol
• 6.6. Global Vasopressor Market, Sub-Segmentation Of Non-Catecholamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phenylephrine
• Angiotensin II
• 6.7. Global Vasopressor Market, Sub-Segmentation Of Vasopressin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Vasopressin (Desmopressin)

7. Vasopressor Market Regional And Country Analysis

• 7.1. Global Vasopressor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vasopressor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vasopressor Market

• 8.1. Asia-Pacific Vasopressor Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vasopressor Market

• 9.1. China Vasopressor Market Overview
• 9.2. China Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vasopressor Market

• 10.1. India Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vasopressor Market

• 11.1. Japan Vasopressor Market Overview
• 11.2. Japan Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vasopressor Market

• 12.1. Australia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vasopressor Market

• 13.1. Indonesia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vasopressor Market

• 14.1. South Korea Vasopressor Market Overview
• 14.2. South Korea Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vasopressor Market

• 15.1. Western Europe Vasopressor Market Overview
• 15.2. Western Europe Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vasopressor Market

• 16.1. UK Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vasopressor Market

• 17.1. Germany Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vasopressor Market

• 18.1. France Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vasopressor Market

• 19.1. Italy Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vasopressor Market

• 20.1. Spain Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vasopressor Market

• 21.1. Eastern Europe Vasopressor Market Overview
• 21.2. Eastern Europe Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vasopressor Market

• 22.1. Russia Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vasopressor Market

• 23.1. North America Vasopressor Market Overview
• 23.2. North America Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vasopressor Market

• 24.1. USA Vasopressor Market Overview
• 24.2. USA Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vasopressor Market

• 25.1. Canada Vasopressor Market Overview
• 25.2. Canada Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vasopressor Market

• 26.1. South America Vasopressor Market Overview
• 26.2. South America Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vasopressor Market

• 27.1. Brazil Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vasopressor Market

• 28.1. Middle East Vasopressor Market Overview
• 28.2. Middle East Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vasopressor Market

• 29.1. Africa Vasopressor Market Overview
• 29.2. Africa Vasopressor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vasopressor Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vasopressor Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vasopressor Market Competitive Landscape And Company Profiles

• 30.1. Vasopressor Market Competitive Landscape
• 30.2. Vasopressor Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck And Co Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Vasopressor Market Other Major And Innovative Companies

• 31.1. Bauch & Lomb Incorporated
• 31.2. Dr. Reddy's Laboratories Limited
• 31.3. Hikma Pharmaceuticals PLC
• 31.4. Endo Inc.
• 31.5. Amphastar Pharmaceuticals Inc.
• 31.6. American Regent Incorporated
• 31.7. Celon Laboratories Ltd.
• 31.8. Athenex Inc.
• 31.9. Sagent Pharmaceuticals Inc.
• 31.10. Civica Rx
• 31.11. Eton Pharmaceuticals Inc.
• 31.12. Amomed Pharma GmbH
• 31.13. Health Biotech Limited
• 31.14. Samarth Life Sciences Pvt. Ltd
• 31.15. Pace Biotech Limited

32. Global Vasopressor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vasopressor Market

34. Recent Developments In The Vasopressor Market

35. Vasopressor Market High Potential Countries, Segments and Strategies

• 35.1 Vasopressor Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vasopressor Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vasopressor Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r35014_Vasopressor_GMR_2025